8VXJ image
Deposition Date 2024-02-04
Release Date 2025-08-27
Last Version Date 2025-09-17
Entry Detail
PDB ID:
8VXJ
Title:
The crystal structure of human apolipoprotein A-I in complex with Fab 55201
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Mus musculus (Taxon ID: 10090)
Method Details:
Experimental Method:
Resolution:
2.70 Å
R-Value Free:
0.29
R-Value Work:
0.26
R-Value Observed:
0.26
Space Group:
P 1 21 1
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Apolipoprotein A-I
Gene (Uniprot):APOA1
Chain IDs:A (auth: C), D
Chain Length:243
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Fab 55201 heavy chain
Chain IDs:B (auth: H), E (auth: A)
Chain Length:224
Number of Molecules:2
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Fab 55201 light chain
Chain IDs:C (auth: L), F (auth: B)
Chain Length:212
Number of Molecules:2
Biological Source:Mus musculus
Primary Citation
The Structure of the Apolipoprotein A-I Monomer Provides Insights Into Its Oligomerisation and Lipid-binding Mechanisms.
J.Mol.Biol. 437 169394 169394 (2025)
PMID: 40816717 DOI: 10.1016/j.jmb.2025.169394

Abstact

Apolipoprotein A-I (apoA-I) plays important roles in clearing cholesterol and phospholipids from peripheral tissues, forming high-density lipoprotein (HDL). However, despite this important function, apoA-I has a propensity to form amyloid fibrils implicated in atherosclerosis and hereditary amyloidosis. Historically, structural determination of lipid-free or lipid-poor apoA-I has been difficult. Here, we obtained the crystal structure of the apoA-I monomer in complex with the antigen-binding fragment (Fab) of a monoclonal antibody. The structure reveals that the N-terminal domain (NTD, residues 1-184) of apoA-I is a compact four-helical bundle, whereas the C-terminal domain (CTD, residues 185-243) is unresolved in the structure. Molecular Dynamics (MD) simulations and small-angle X-ray scattering (SAXS) analysis revealed that the apoA-I NTD dimerises by domain-swapping and the dimer is elongated. Methionine (Met) oxidation in apoA-I destabilises both full-length apoA-I (apoA-IFL) and C-terminally truncated apoA-I (apoA-IΔ185-243), causing dissociation of the domain-swapped dimer and fibril formation. Met oxidation also increased the lipid-binding ability of apoA-IΔ185-243, while the amyloidogenic mutation, G26R, did not. Hydrogen-deuterium exchange coupled with nuclear magnetic resonance (HDX-NMR), SAXS, and MD analyses showed that triply Met-oxidised (3MetO) and G26R apoA-IΔ185-243 are both highly dynamic but remain partially folded. Based on these results, we propose that domain-swapping dimerisation also exists in apoA-IFL, with the CTD mediating further oligomerisation. We also propose that lipid-binding is promoted by increased global destabilisation in the protein structure, and/or driven by a specific local conformation that is induced by Met-oxidation but not the G26R mutation.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback